Abiopharma

🔍 CHERESKIN BENJAMIN D (Executive)

Company: Cinemark Holdings, Inc. (CNK)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 5,439 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: A | equity_swap_involved: false | shares_owned_after: 108,148.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: H | nature_of_ownership: By limited partnership | shares_owned_after: 3,568.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: H | nature_of_ownership: By trust | shares_owned_after: 9,736.00 | Footnotes: F3

Footnotes:

• F1: Annual award of restricted stock pursuant to the director compensation policy. Par value is $0.001 per share.
• F2: These shares are held by LEGATUM Partners, L.P., of which shares Mr. Chereskin is the beneficial owner.
• F3: These shares are held in a grantor trust. Mr. Chereskin's spouse is a trustee of the trust.